Radius Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RADIUS, and what generic alternatives to RADIUS drugs are available?
RADIUS has two approved drugs.
There are ten US patents protecting RADIUS drugs.
There are sixty-three patent family members on RADIUS drugs in thirty-one countries and eight supplementary protection certificates in seven countries.
Summary for Radius
| International Patents: | 63 |
| US Patents: | 10 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
| Patent Litigation for Radius: | See patent lawsuits for Radius |
Drugs and US Patents for Radius
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Radius | TYMLOS | abaloparatide | SOLUTION;SUBCUTANEOUS | 208743-001 | Apr 28, 2017 | RX | Yes | Yes | 10,996,208 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Radius | TYMLOS | abaloparatide | SOLUTION;SUBCUTANEOUS | 208743-001 | Apr 28, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Radius | TYMLOS | abaloparatide | SOLUTION;SUBCUTANEOUS | 208743-001 | Apr 28, 2017 | RX | Yes | Yes | 11,782,041 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Radius | TYMLOS | abaloparatide | SOLUTION;SUBCUTANEOUS | 208743-001 | Apr 28, 2017 | RX | Yes | Yes | RE49444 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Radius | TYMLOS | abaloparatide | SOLUTION;SUBCUTANEOUS | 208743-001 | Apr 28, 2017 | RX | Yes | Yes | 7,803,770 | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Radius
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Radius | BINOSTO | alendronate sodium | TABLET, EFFERVESCENT;ORAL | 202344-001 | Mar 12, 2012 | 7,488,496 | ⤷ Sign Up |
| Radius | BINOSTO | alendronate sodium | TABLET, EFFERVESCENT;ORAL | 202344-001 | Mar 12, 2012 | 7,964,212 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Radius Drugs
Supplementary Protection Certificates for Radius Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2073789 | CA 2023 00019 | Denmark | ⤷ Sign Up | PRODUCT NAME: ABALOPARATID; REG. NO/DATE: EU/1/22/1706 20221213 |
| 2073789 | 2023C/523 | Belgium | ⤷ Sign Up | PRODUCT NAME: ABALOPARATIDE; AUTHORISATION NUMBER AND DATE: EU/1/22/1706 20221213 |
| 2073789 | 2390018-6 | Sweden | ⤷ Sign Up | PRODUCT NAME: ABALOPARATIDE; REG. NO/DATE: EU/1/22/1706 20221213 |
| 2073789 | 122023000031 | Germany | ⤷ Sign Up | PRODUCT NAME: ABALOPARATID; REGISTRATION NO/DATE: EU/1/22/1706 20221212 |
| 2073789 | LUC00309 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: ABALOPARATIDE; AUTHORISATION NUMBER AND DATE: EU/1/22/1706 20221213 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
